Skip to main contentSkip to navigation
Sirius Investors
ALK-Abelló A/S

ALK-Abelló A/S

AKBLF
OTCHealthcare

ALK-Abelló A/S (AKBLF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate ALK-Abelló A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
42.33
Weak
WeakModerateStrong
P/B Ratio
7.86
Weak
WeakModerateStrong
Earnings Yield
2.36%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
18.57%
Strong
WeakModerateStrong
Operating Margin
26.35%
Strong
WeakModerateStrong
Net Profit Margin
18.96%
Strong
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
13.74%
Strong
WeakModerateStrong
Net Income Growth
46.54%
Strong
WeakModerateStrong
EPS Growth
47.01%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
3.38
Strong
WeakModerateStrong
Quick Ratio
2.04
Strong
WeakModerateStrong
Asset Turnover
0.69x
Moderate
WeakModerateStrong
Inventory Turnover
1.21x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
3.04%
Moderate
WeakModerateStrong
EV / Free Cash Flow
32.33x
Moderate
WeakModerateStrong
Net Debt / EBITDA
-0.42x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.983
Strong
WeakModerateStrong
Return on Invested Capital
15.40%
Moderate
WeakModerateStrong
Cash Conversion Cycle
355.38 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for AKBLF.

View Financial Statements